189 related articles for article (PubMed ID: 22688335)
1. Intrarenal dopamine inhibits progression of diabetic nephropathy.
Zhang MZ; Yao B; Yang S; Yang H; Wang S; Fan X; Yin H; Fogo AB; Moeckel GW; Harris RC
Diabetes; 2012 Oct; 61(10):2575-84. PubMed ID: 22688335
[TBL] [Abstract][Full Text] [Related]
2. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.
Yang S; Yao B; Zhou Y; Yin H; Zhang MZ; Harris RC
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F742-9. PubMed ID: 22169008
[TBL] [Abstract][Full Text] [Related]
3. Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney.
Zhang MZ; Wang Y; Yao B; Gewin L; Wei S; Capdevila JH; Harris RC
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1680-6. PubMed ID: 24154693
[TBL] [Abstract][Full Text] [Related]
4. Intrarenal dopaminergic system regulates renin expression.
Zhang MZ; Yao B; Fang X; Wang S; Smith JP; Harris RC
Hypertension; 2009 Mar; 53(3):564-70. PubMed ID: 19139376
[TBL] [Abstract][Full Text] [Related]
5. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
Zhang MZ; Yao B; Wang S; Fan X; Wu G; Yang H; Yin H; Yang S; Harris RC
J Clin Invest; 2011 Jul; 121(7):2845-54. PubMed ID: 21701066
[TBL] [Abstract][Full Text] [Related]
6. Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.
Yao B; Harris RC; Zhang MZ
Hypertension; 2009 Nov; 54(5):1077-83. PubMed ID: 19770404
[TBL] [Abstract][Full Text] [Related]
7. The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.
Eriguchi M; Bernstein EA; Veiras LC; Khan Z; Cao DY; Fuchs S; McDonough AA; Toblli JE; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
J Am Soc Nephrol; 2018 Oct; 29(10):2546-2561. PubMed ID: 30185469
[TBL] [Abstract][Full Text] [Related]
8. Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload.
Chaudhary K; Chilakala A; Ananth S; Mandala A; Veeranan-Karmegam R; Powell FL; Ganapathy V; Gnana-Prakasam JP
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F512-F517. PubMed ID: 31188032
[TBL] [Abstract][Full Text] [Related]
9. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
[TBL] [Abstract][Full Text] [Related]
11. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats.
Lal MA; Körner A; Matsuo Y; Zelenin S; Cheng SX; Jaremko G; DiBona GF; Eklöf AC; Aperia A
Diabetes; 2000 Aug; 49(8):1381-9. PubMed ID: 10923641
[TBL] [Abstract][Full Text] [Related]
12. Saccharomyces boulardii exerts renoprotection by modulating oxidative stress, renin angiotensin system and uropathogenic microbiota in a murine model of diabetes.
Abreu ICME; Albuquerque RCMF; Brandão ABP; Barssotti L; de Souza LB; Ferreira FG; Oliveira LCG; Yokota R; Sparvoli LG; Dias DDS; Salgado MAC; Taddei C; De Angelis K; Casarini DE; Cunha TS
Life Sci; 2022 Jul; 301():120616. PubMed ID: 35533758
[TBL] [Abstract][Full Text] [Related]
13. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
[TBL] [Abstract][Full Text] [Related]
14. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II and its receptors in the diabetic kidney.
Burns KD
Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.
Chang SY; Chen YW; Chenier I; Tran Sle M; Zhang SL
Exp Diabetes Res; 2011; 2011():521076. PubMed ID: 22110472
[TBL] [Abstract][Full Text] [Related]
17. The role of adrenomedullin in the renal NADPH oxidase and (pro)renin in diabetic mice.
Hayashi M; Tojo A; Shimosawa T; Fujita T
J Diabetes Res; 2013; 2013():134395. PubMed ID: 23957015
[TBL] [Abstract][Full Text] [Related]
18. The intrarenal renin-angiotensin system and diabetic nephropathy.
Carey RM; Siragy HM
Trends Endocrinol Metab; 2003 Aug; 14(6):274-81. PubMed ID: 12890592
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic Dysfunction in Mammalian Dopamine Neurons Induced by Simazine Neurotoxicity.
Li X; Yu J; Li J; Wu Y; Li B
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29137186
[TBL] [Abstract][Full Text] [Related]
20. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.
Eriguchi M; Lin M; Yamashita M; Zhao TV; Khan Z; Bernstein EA; Gurley SB; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F531-F542. PubMed ID: 29187372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
